Valued Wealth Advisors LLC Grows Stake in The Procter & Gamble Company (NYSE:PG)

Valued Wealth Advisors LLC grew its position in The Procter & Gamble Company (NYSE:PGFree Report) by 11.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 605 shares of the company’s stock after buying an additional 61 shares during the quarter. Valued Wealth Advisors LLC’s holdings in Procter & Gamble were worth $105,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in PG. International Assets Investment Management LLC lifted its holdings in Procter & Gamble by 19,030.8% during the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock worth $639,730,000 after buying an additional 3,674,286 shares during the period. Wulff Hansen & CO. lifted its stake in shares of Procter & Gamble by 16,292.0% during the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock worth $606,230,000 after purchasing an additional 3,653,477 shares during the last quarter. TD Asset Management Inc boosted its position in Procter & Gamble by 114.9% during the first quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after purchasing an additional 1,907,716 shares in the last quarter. AMF Tjanstepension AB boosted its holdings in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after buying an additional 1,466,115 shares in the last quarter. Finally, Swedbank AB purchased a new position in shares of Procter & Gamble in the 1st quarter worth approximately $233,788,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 389,144 shares of company stock worth $66,184,385 in the last quarter. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG traded up $0.87 during mid-day trading on Friday, hitting $166.05. 335,501 shares of the company were exchanged, compared to its average volume of 6,622,219. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The stock has a market cap of $391.05 billion, a price-to-earnings ratio of 28.48, a price-to-earnings-growth ratio of 3.59 and a beta of 0.41. The company has a 50 day moving average of $171.70 and a 200-day moving average of $167.84.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the company posted $1.83 EPS. The firm’s quarterly revenue was down .6% on a year-over-year basis. Analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.42%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. DA Davidson boosted their target price on Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research note on Monday, October 21st. Citigroup upped their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Evercore ISI lifted their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. TD Cowen began coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Finally, Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Get Our Latest Stock Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.